Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.100
-0.010 (-0.24%)
At close: Mar 28, 2025, 4:00 PM
3.910
-0.190 (-4.64%)
Pre-market: Mar 31, 2025, 8:48 AM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $136.11 million as of March 31, 2025. Its market cap has decreased by -69.19% in one year.
Market Cap
136.11M
Enterprise Value
24.51M
1-Year Change
-69.19%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $136.11M, a decrease of -49.84%. That is a compound annual growth rate of -38.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 136.11M | -37.46% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |